What is the debt of Savara this year?
Savara has a debt level of -0.24 USD this year.
Savara Debt 2024
Savara Debt
-0.24 USD
Ticker
SVRA
ISIN
US8051111016
WKN
A2DQ2B
In 2024, Savara's total debt was -0.24 USD, a -99.09% change from the -26 USD total debt recorded in the previous year.
Savara Aktienanalyse
What does Savara do?
Savara Inc is a US biotechnology company specializing in the development and commercialization of therapies for rare respiratory diseases. The company was founded in 2007 and is headquartered in Austin, Texas. Savara initially focused on treating cystic fibrosis, a genetic disease that can cause severe lung problems. The company developed an innovative therapy based on the use of liposomes, tiny bubbles that can deliver medication directly to the lungs. This method was considered promising and received orphan drug status from the FDA, meaning it is intended for the treatment of rare diseases. However, due to high costs associated with developing and approving a new medication for cystic fibrosis, Savara decided to redefine its goals and focus on other rare respiratory diseases. The company's business model is based on identifying promising therapy approaches for these diseases and developing them into approvable medications. Savara collaborates closely with leading experts and scientists in the field of respiratory diseases. Its main therapy areas include cystic fibrosis, pulmonary fibrosis, and rare lung diseases. Savara has a special focus on developing liposome-based therapies, which have the potential to target the affected areas in the lungs and enhance the effects of other medications. Currently, the company offers three products: - AeroVanc: A liposome-based inhaled antibiotic used to treat cystic fibrosis-induced chronic lung infections. AeroVanc is the first FDA-approved medication in Savara's history. - Molgradex: A recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) being developed for the treatment of autoimmune pulmonary alveolitis (also known as extrinsic allergic alveolitis). - AVAIL: A liposome-based inhaled antibiotic currently in Phase II of clinical development, being developed to treat non-tuberculous mycobacterial (NTM) lung infections. Savara has also formed partnerships with other companies and organizations to advance its research and development. Partners include the Cystic Fibrosis Foundation, the National Institutes of Health (NIH), and the European Respiratory Society. In summary, Savara Inc is a biotechnology company focused on developing therapies for rare respiratory diseases. The company has developed a promising technology platform and collaborates closely with leading experts and scientists in the field. Savara has a range of products on the market, including the first FDA-approved medication in the company's history. Savara ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Savara's Debt Structure
Savara's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Savara's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Savara’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Savara’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Savara stock
What was the debt of Savara compared to the previous year?
The debt of Savara has increased by -99.09% compared to the previous year dropped.
What are the consequences of high debt for investors in Savara?
High debt can pose a risk for investors of Savara, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Savara?
Low debt means that Savara has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Savara affect the company?
An increase in debt of Savara can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Savara affect the company?
A reduction in debt of Savara can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Savara?
Some factors that can influence the debt of Savara include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Savara so important for investors?
The debts of Savara are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Savara take to change the debt?
To change the debt, Savara can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Savara pay?
Over the past 12 months, Savara paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Savara is expected to pay a dividend of 0 USD.
What is the dividend yield of Savara?
The current dividend yield of Savara is .
When does Savara pay dividends?
Savara pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Savara?
Savara paid dividends every year for the past 0 years.
What is the dividend of Savara?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Savara located?
Savara is assigned to the 'Health' sector.
Wann musste ich die Aktien von Savara kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Savara from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.
When did Savara pay the last dividend?
The last dividend was paid out on 10/1/2024.
What was the dividend of Savara in the year 2023?
In the year 2023, Savara distributed 0 USD as dividends.
In which currency does Savara pay out the dividend?
The dividends of Savara are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Savara
Our stock analysis for Savara Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Savara Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
